2JP1 image
Deposition Date 2007-04-17
Release Date 2008-03-11
Last Version Date 2024-11-20
Entry Detail
PDB ID:
2JP1
Keywords:
Title:
Solution structure of the alternative conformation of XCL1/Lymphotactin
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
100
Conformers Submitted:
20
Selection Criteria:
target function
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Lymphotactin
Gene (Uniprot):XCL1
Chain IDs:A, B
Chain Length:93
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Interconversion between two unrelated protein folds in the lymphotactin native state
Proc.Natl.Acad.Sci.Usa 105 5057 5062 (2008)
PMID: 18364395 DOI: 10.1073/pnas.0709518105

Abstact

Proteins often have multiple functional states, which might not always be accommodated by a single fold. Lymphotactin (Ltn) adopts two distinct structures in equilibrium, one corresponding to the canonical chemokine fold consisting of a monomeric three-stranded beta-sheet and carboxyl-terminal helix. The second Ltn structure solved by NMR reveals a dimeric all-beta-sheet arrangement with no similarity to other known proteins. In physiological solution conditions, both structures are significantly populated and interconvert rapidly. Interconversion replaces long-range interactions that stabilize the chemokine fold with an entirely new set of tertiary and quaternary contacts. The chemokine-like Ltn conformation is a functional XCR1 agonist, but fails to bind heparin. In contrast, the alternative structure binds glycosaminoglycans with high affinity but fails to activate XCR1. Because each structural species displays only one of the two functional properties essential for activity in vivo, the conformational equilibrium is likely to be essential for the biological activity of lymphotactin. These results demonstrate that the functional repertoire and regulation of a single naturally occurring amino acid sequence can be expanded by access to a set of highly dissimilar native-state structures.

Legend

Protein

Chemical

Disease

Primary Citation of related structures